Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSchroders Regulatory News (SOI)

Share Price Information for Schroders (SOI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 265.00
Bid: 263.00
Ask: 265.00
Change: 1.50 (0.57%)
Spread: 2.00 (0.76%)
Open: 264.00
High: 265.00
Low: 263.00
Prev. Close: 263.50
SOI Live PriceLast checked at -
Schroder Oriental Income is an Investment Trust

To provide total return through investments in equities and equity related investments in companies, which are based in or derive a significant proportion of revenues from the Asia Pacific region.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

5 May 2021 07:00

RNS Number : 5368X
Schroder Oriental Income Fund Ltd
05 May 2021
 

5 May 2021

Half Year Report

 

Schroder Oriental Income Fund Limited hereby submits its Half Year Report for the period ended 28 February 2021 as required by the UK Listing Authority's Disclosure Guidance and Transparency Rule 4.2.

 

The Half Year Report is also being published in hard copy format and an electronic copy of that document will shortly be available to download from the Company's webpages https://www.schroders.co.uk/orientalincome. Please click on the following link to view the document:

 

http://www.rns-pdf.londonstockexchange.com/rns/5368X_1-2021-5-4.pdf

 

The Company has submitted its Half Year Report to the National Storage Mechanism and it will shortly be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

Enquiries:

 

Matthew Riley

Schroder Investment Management Limited

Tel: 020 7658 6596

 

 

Chairman's Statement

 

I am delighted to present my first statement as Chairman of Schroder Oriental Income Fund Limited.

 

The six months to 28 February 2021 were marked by a continuation of the strong rally from the low in equity markets in March last year and, indeed, as I write this, that rally continues unabated. The picture, however, is more complex than headline indices might suggest. Under the surface of markets there has been the beginning of a rotation from "growth" towards "value". I use these market-convention terms loosely because I am not convinced that they describe accurately the process itself or its impact upon the Company. For a number of years, the Company faced a headwind: much of the strength of broad stock markets was derived from a very narrow group of technology related names. This was especially the case in the Chinese market with the meteoric rise of Tencent, Baidu, Alibaba and others. These stocks do not have a natural home in the Company's portfolio because of their limited dividends (and in some cases a lack of earnings). Our performance had been more than creditable with this back drop. But, fundamentally, the Company would always face a challenge in keeping up with indices driven by extreme outperformance of a few technology names.

 

Since November, as vaccine news improved and the extent of US fiscal stimulus became clear after the US election, sentiment towards a broad economic recovery has improved. As a result, a rotation has started, away from this narrow grouping and towards sectors where the Company's approach to identify strong balance sheets, sustainable dividend growth and robust business models means we are more heavily represented.

 

Accordingly, I am pleased to be able to report a period of both strong absolute and strong relative performance. The Company does not have a formal benchmark and the Investment Manager is not shackled in any way to the composition of the broad Asian indices. Their freer thinking approach has served shareholders well for many years. Nonetheless, to have a reference point to help judge the outcome is always useful. During the six month period, the Company generated a total return of 20.6% vs the MSCI AC Pacific ex Japan index return of 16.7%. Similarly, our performance against our peers was pleasing.

 

The Company's share price slipped to a discount to Net Asset Value ("NAV") last spring. The board believes that itis important that the Company be as willing to repurchase shares at appropriate moments as it is to issue when the share price is at a premium. Accordingly, on occasions when there was a clear imbalance in the market for the Company's shares, we were happy to repurchase shares and during the six month period we repurchased 2,025,000 shares at an average discount to NAV of 5.7%. More recently, the share price has moved to within touching distance of the NAV and I hope that when I next write to you I will be able to report that we are back to NAV or at a small premium, which has been the long term position of the Company.

 

During the six month period, the Company declared two interim dividends, totalling 3.8p, the same as last year. Asian economies have, generally, shown remarkable resilience as the pandemic has progressed and recent growth numbers from China have been very strong. That said, it was inevitable that regional earnings and dividends would come under some pressure. The Company used a modest amount of its revenue reserves during 2020. It seems entirely sensible, when you have built reserves over many years for a rainy day, to use some of them when you need to keep dry. If needed, we will do the same again in 2021 to deal with any timing issues as dividend growth may not resume meaningfully for some months yet. However, absent an unexpected deterioration, the outlook for earnings in the region looks strong over the coming years and this further underpins the investment case for the Company. Indeed, the value of Asia as a diversifying source of income to investors has been demonstrated once again, with Asian dividends proving much more resilient than UK dividends.

 

As many of you will be aware, at the turn of 2021 Matthew Dobbs retired from leading the management of the Company's portfolio. Matthew was a pioneer in foreseeing the opportunity to invest in Asia for income some 16 years ago. In that time, drawing upon the strength and depth of Schroder's analysts in the region, he helped the Company build an enviable track record of capital growth and dividend growth. I would like to reiterate my predecessor's thanks to Matthew. I have no doubt that Richard Sennitt, who worked alongside Matthew for 13 years, and Abbas Barkhordar will bring their own stamp to the Company's management in the future. But the essential ingredients and approach remain the same and as attractive as ever. Schroder's insight in the region remains preeminent and the opportunity for active fund management to deliver value remains superior to Europe or North America. In 2005, when the Company launched, Asia represented less than a fifth of global GDP. Today, it represents around one third. The long term prospects for investing in the region and earning growing income from the best companies remains undimmed.

 

One significant change that has occurred in those 16 years, however, is the increasing investor focus on environmental, social and governance (ESG) issues in investing. Despite expectations to the contrary, the pandemic has sharpened rather than diminished the focus on ESG in investors' minds. I believe that there is no need for investors to purchase dedicated ESG funds, with their inherent issues, to benefit from a focus on good governance, social outcomes and environmental sustainability. At Schroders, ESG has long been instinctive and interwoven into day to day investment decision making. That said, I do think that it is beholden on us to explain this better to our shareholders in future and I anticipate that we will do this more clearly and effectively going forward.

 

I noted earlier the shift from "growth" investing back towards a "value" style which should, once again, put the wind behind our back. Whether this trend will persist will depend upon continued and sustainable economic recovery. This seems probable, even if equity markets may have already anticipated the first leg of this recovery. Despite the extent of the recent rotation towards value, in reality it has barely begun to turn the multi-year cycle that prevailed before. This trend could have much further to run. Equity markets in the short term may benefit from a pause that refreshes and there is always the likelihood of volatility with the asset class. But this is unlikely to diminish the benefits of the strong balance sheets and robust earnings that underpin our own returns to shareholders. The prospect remains for further capital gains alongside a robust income distribution from the Company.

 

I look forward to reporting to you again in the autumn with the annual financial statements but my colleagues and I on the board always welcome any questions or observations that you may have in the meantime. If you would like to get in touch, please do contact us at amcompanysecretary@schroders.com.

 

 

Paul Meader

Chairman

4 May 2021

 

Interim Management Report - Manager's Review

 

The net asset value per share of the company recorded a total return of +20.6% over the six months to end February 2021. Two interim dividends have been declared totalling 3.80p (3.80p last year).

 

As the chart on page 5 of the 2021 half year report illlustrates, equity markets made strong progress through the latter part of last year and the start of 2021, buoyed by improving export data, strong liquidity, a weakening dollar and progress on the development of a number of vaccines for COVID-19. This was accompanied by a wider range of stocks seeing positive earnings revisions, which subsequently saw market returns start to broaden out, having previously been heavily dominated by a relatively narrow set of growth stocks.

 

North Asia continued to manage the COVID crisis well whilst many economies across Europe and the Americas experienced second waves. A number of these economies saw renewed lockdowns whereas economies such as China started to normalise with domestic growth recovering in addition to the strong export recovery. Although the run up to the US election saw increased tensions between China and the US over a wide range of issues, the new US administration added fuel to the global recovery with hopes of increased fiscal stimulus. This in turn saw long bond yields start to move up which periodically started to unsettle markets.

 

Sector returns across the region reflected the rotation in the markets that has been seen globally and was particularly marked from November following the vaccine news and hopes for more fiscal stimulus following the US election, which raised expectations for a stronger global recovery. Defensive bond like names in sectors such as utilities, consumer staples and health care lagged as growth expectations picked up and rising long bond yields impacted valuations. The areas seen as the bigger beneficiaries of recovering global growth and the move up in interest rates, including information technology, materials and some financials, outperformed. Beneficiaries of pandemic-related restrictions being eased still found life tough given the flare-ups of COVID seen regionally and more sustained waves globally.

 

The spread of returns across the regional markets continued to be high with technology-heavy Korea and Taiwan both up over 30% for the period, benefiting from upward earnings revisions driven by ongoing strong export demand for semiconductors and technology products. These were the only two markets that outperformed the index return over the period. The Chinese market started the period robustly as growth names did well but faded after the e-commerce platform names came under increased regulatory scrutiny into their market positioning as well as investors regionally starting to rotate out of some of the more thematic growth names that had performed strongly. ASEAN markets continued to lag hampered by a lack of technology stocks to be found in their public markets and fears that they would suffer disproportionately from any COVID second wave, as well as general investor ambivalence towards some of the smaller markets.

 

Although the broad backdrop points to a recovery in earnings this year, the dividend payment picture across the period was more mixed given its tendency to lag that of earnings. In general, North Asian payments were relatively more robust reflecting the better economic backdrop and exposure to sectors that had not been hit as hard by COVID, such as technology stocks. Financials generally through 2020 were impacted by falling interest rates and uncertainty over credit costs relating to COVID, which together with regulatory limits imposed on shareholder returns, in some countries, saw the sector under pressure from a dividend perspective, with cuts in a number of markets including Singapore and Australia. The other headwind for dividends has been the uncertainty over the pace of any recovery given second and third waves of COVID globally, as well as flare-ups regionally, which have resulted in sporadic localised lockdowns, all of which unsurprisingly has prioritised caution.

 

Positioning and Performance

 

The Company's positive total return of 20.6% over the period compared favourably with that of the reference benchmark which rose 16.7% over the period. The increased expectations for a global recovery benefitted the trust as it saw earnings revisions broaden out from a narrow set of growth names, many of which pay little in the way of dividend (including the Chinese internet names). Over the period the biggest positive contribution came from our stock selection in and overweight to Taiwan where our technology names performed particularly strongly. The underweight to China, which lagged over the period, also benefitted the trust albeit part of that was offset by the overweight to Hong Kong. Elsewhere, stock selection in Australia via overweights in the diversified resource companies added value. Stock selection in and our overweight to Singapore was a headwind with many of the REIT (Real Estate Investment Trust) names lagging as rate expectations ticked up and 'normalisation' was delayed. The underweight to the smaller markets of Malaysia, Indonesia and the Philippines, in part, offset this.

 

The geographic exposure in the Company's portfolio continues to be spread between Taiwan, Hong Kong, Australia, Korea, China and Singapore. China remains a substantial underweight but is, in part, offset by the overweight to Hong Kong. Moves over the period have tended to take advantage of the increased valuation spread that we saw through last year, reducing those stocks that performed particularly strongly and now look more fully valued in favour of those names that have lagged and look more attractive from a valuation perspective. This involved adding to financials, including in some of the South East Asian markets, and taking profits on some of the more growth orientated names in North Asia that had done particularly well, including some names in the information technology sector. Real estate remains an important exposure, but we have taken a very selective approach both in terms of the nature of the underlying asset and also balance sheet strength.

 

Investment Outlook

 

Despite the threat to human life from COVID-19 and its consequent impact on the global economy, stock markets have risen strongly over the last year driven by a cocktail of liquidity, fiscal stimulus, hopes of a successful vaccine rollout and the prospect of a recovery in earnings. Aggregate valuations are now well above long term averages and increasingly starting to price in a strong recovery in earnings. However, the wide divergence of valuations and prospect for the broadening of the earnings recovery means that, although, there are some areas of the market that look 'frothy', such as in selective EV, biotech and tech names, other areas of the market have lagged and are still trading on relatively attractive valuations despite the recent rotation in the market which has seen some of the valuation disparities start to narrow.

 

Sources of volatility are easy to identify from the new US administration's fiscal and foreign policy, the ongoing relationship between themselves and China to the potential for a further COVID induced slowdown. The recent rise in US long bond yields has unsettled investors given the potential impact that this could have not only on valuations, especially of more highly rated growth stocks, but also in it potentially bringing forward tightening of monetary policy that has been so accommodative for markets. Any tapering of monetary policy clearly remains a risk and we have started to see some price rises in commodities and goods inflation due to shortages as economies open up, however, services demand is likely to lag resulting in subdued wage pressure in most developed markets. Inflation rising faster than expected is not great for equities in the short-term, but longer term real asset income sources should look attractive versus the return free risk that is fixed income.

 

Looking at dividends more broadly, there is still a lot of uncertainty as to where near term payments will go given the path of COVID which has unsurprisingly meant caution from some companies, particularly those most reliant on pandemic-related restrictions being eased. Still, despite this, we are expecting earnings to pick up this year as described above which should provide a more supportive backdrop for dividends and potential increases, albeit the timing around increases remains COVID dependent with the uncertainty resulting in a potential lag between any recovery in earnings and that of dividends. Some financials payouts, for instance, remain capped by their regulators but if we see ongoing recovery we are hoping that they will start to allow increased payments. From an overall fund distribution perspective the other dynamic to be cognisant of is Sterling whose direction will obviously impact the size of translated dividends.

 

Schroder Investment Management Limited

4 May 2021

 

Principal risks and uncertainties

 

The principal risks and uncertainties with the Company's business fall into the following risk categories: strategic; investment management; financial and currency; political; custody; gearing and leverage; accounting, legal and regulatory; service provider and cyber.

 

A detailed explanation of the risks and uncertainties in each of these categories can be found on pages 18 and 21 of the Company's published annual report and accounts for the year ended 31 August 2020.

 

These principal risks and uncertainties have not materially changed during the six months ended 28 February 2021.

 

The board has continued to keep under review the effect of the COVID-19 pandemic on the Company's principal risks and uncertainties. Although it was assessed to be an emerging risk in the annual report, the board now considers that the Company's existing principal risks and uncertainties are sufficiently comprehensive. COVID-19 continues to affect the Company, affecting the value of the Company's investments due to the disruption of supply chains and demand for products and services, increased costs and cash flow problems, and changed legal and regulatory requirements for companies. The pandemic has had a significant impact on prospects for global growth and it continues to create uncertainty in many sectors

 

The board notes the Manager's investment process has been unaffected by the COVID-19 pandemic. The Manager continues to focus on long-term company fundamentals and detailed analysis of current and future investments. COVID-19 also affected the Company's service providers, who have implemented business continuity plans and are working almost entirely remotely. The board continues to receive regular reporting on operations from the Company's major service providers and does not anticipate a fall in the level of service.

 

Going concern

 

The board has assessed the principal risks and uncertainties, along with the Company's current financial position, its cash flows and its liquidity. The board notes that the Company's portfolio is comprised of mainly large cap equities in liquid markets, that the Company has low levels of gearing, which are kept under review by the board, and that the Company has a low level of, mostly, variable costs. The board has reviewed the impact on the risks as a result of COVID-19, and where appropriate, action taken by the Company's service providers in relation to those risks and the directors consider it appropriate to adopt the going concern basis in preparing the accounts.

 

Related party transactions

 

There have been no transactions with related parties that have materially affected the financial position or the performance of the Company during the six months ended 28 February 2021.

 

Directors' responsibility statement

 

The directors confirm that, to the best of their knowledge, this set of condensed financial statements has been prepared in accordance with the Companies (Guernsey) Law, 2008, International Financial Reporting Standards and with the Statement of Recommended Practice, "Financial Statements of Investment Companies and Venture Capital Trusts" issued in October 2019 and that this Interim Management Report includes a fair review of the information required by 4.2.7R and 4.2.8R of the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

 

Statement of Comprehensive Income

 

 

(Unaudited)

For the six months ended

28 February 2021

(Unaudited)

For the six months ended

29 February 2020

(Audited)

For the year ended

31 August 2020

 

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Revenue

£'000

Capital

£'000

Total

£'000

Gains/(losses) on investments held at fair value through profit or loss

-

129,359

 129,359

-

(42,903)

 (42,903)

 -

(33,379)

 (33,379)

Net foreign currency gains

-

962

 962

-

711

 711

 -

3,536

 3,536

Income from investments

 10,791

219

 11,010

 10,031

62

 10,093

 31,421

164

 31,585

Other income

1

-

 1

11

-

 11

12

-

 12

Total income/(loss)

10,792

130,540

141,332

10,042

(42,130)

(32,088)

31,433

(29,679)

1,754

Management fee

 (771)

(1,799)

 (2,570)

 (687)

(1,604)

 (2,291)

 (1,355)

(3,163)

 (4,518)

Performance fee

 -

(5,356)

 (5,356)

 -

-

 -

 -

-

 -

Administrative expenses

(534)

(3)

 (537)

(483)

(2)

 (485)

 (1,051)

 (4)

 (1,055)

Profit/(loss) before finance costs and taxation

 9,487

 123,382

 132,869

 8,872

 (43,736)

 (34,864)

 29,027

 (32,846)

 (3,819)

Finance costs

 (52)

 (115)

 (167)

 (125)

 (290)

 (415)

 (235)

 (528)

 (763)

Profit/(loss) before taxation

 9,435

 123,267

 132,702

 8,747

 (44,026)

 (35,279)

 28,792

 (33,374)

 (4,582)

Taxation (note 4)

 (811)

 -

 (811)

 (707)

 -

 (707)

 (2,255)

 -

 (2,255)

Net profit/(loss) and total comprehensive income

 8,624

 123,267

 131,891

 8,040

 (44,026)

 (35,986)

 26,537

 (33,374)

 (6,837)

Earnings/(losses) per share (note 5)

3.20p

45.76p

48.96p

3.00p

(16.44)p

(13.44)p

9.86p

(12.40)p

(2.54)p

 

The "Total" column of this statement represents the Company's Statement of Comprehensive Income, prepared in accordance with International Financial Reporting Standards. The "Revenue" and "Capital" columns represent supplementary information prepared under guidance issued by the Association of Investment Companies. The Company has no other items of other comprehensive income, and therefore the net profit/(loss) for the period is also the total comprehensive income for the period.

All revenue and capital items in the above statement derive from continuing operations. No operations were acquired or discontinued in the period.

 

Statement of Changes in Equity

 

For the six months ended 28 February 2021 (unaudited)

 

 

 

Share capital

£'000

Treasury

share reserve

£'000

Capital redemption

reserve

£'000

 

Special reserve

£'000

 

Capital reserves

£'000

 

Revenue reserve

£'000

 

 

Total

£'000

At 31 August 2020

234,347

(2,155)

39

150,374

233,856

30,238

646,699

Issue of shares

-

-

-

-

-

-

-

Repurchase of shares into treasury

-

(5,233)

-

-

-

-

(5,233)

Net profit

-

-

-

-

123,267

8,624

131,891

Dividends paid in the period (note 6)

-

-

-

-

-

(17,504)

(17,504)

At 28 February 2021

234,347

(7,388)

39

150,374

357,123

21,358

755,853

 

For the six months ended 29 February 2020 (unaudited)

 

 

 

Share capital

Treasury

share reserve

Capital redemption

reserve

 

Special reserve

 

Capital reserves

 

Revenue reserve

 

 

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 31 August 2019

212,786

-

39

150,374

267,230

31,375

661,804

Issue of shares

19,397

-

-

-

-

-

19,397

Net (loss)/profit

-

-

-

-

(44,026)

8,040

(35,986)

Dividends paid in the period (note 6)

-

-

-

-

-

(17,401)

(17,401)

At 29 February 2020

232,183

-

39

150,374

223,204

22,014

627,814

 

For the year ended 31 August 2020 (audited)

 

 

 

Share capital

Treasury

share reserve

Capital redemption

reserve

 

Special reserve

 

Capital reserves

 

Revenue reserve

 

 

Total

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 31 August 2019

212,786

-

39

150,374

267,230

31,375

661,804

Issue of shares

21,561

-

-

-

-

-

21,561

Repurchase of shares into treasury

-

(2,155)

-

-

-

-

(2,155)

Net (loss)/profit

-

-

-

-

(33,374)

26,537

(6,837)

Dividends paid in the year (note 6)

-

-

-

-

-

(27,674)

(27,674)

At 31 August 2020

234,347

(2,155)

39

150,374

233,856

30,238

646,699

 

 

Balance Sheet

 

at 28 February 2021 (unaudited)

 

 

(Unaudited)

28 February

2021

£'000

(Unaudited)

29 February

2020

£'000

(Audited)

31 August

2020

£'000

Non current assets

Investments at fair value through profit or loss

 

785,355

 

669,838

 

672,184

Current assets

Receivables

 

8,556

 

6,518

 

5,234

Cash and cash equivalents

6,272

14,326

17,028

 

14,828

20,844

22,262

Total assets

800,183

690,682

694,446

Current liabilities

Bank loans

 

(35,763)

 

(61,205)

 

(42,625)

Payables

(8,567)

(1,302)

(5,122)

Derivative financial instruments held at fair value through profit or loss

-

(361)

-

 

(44,330)

(62,868)

(47,747)

Net assets

755,853

627,814

646,699

Equity attributable to equity holders

Share capital (note 7)

 

234,347

 

232,183

 

234,347

Treasury share reserve

(7,388)

-

(2,155)

Capital redemption reserve

39

39

39

Special reserve

150,374

150,374

150,374

Capital reserves

357,123

223,204

233,856

Revenue reserve

21,358

22,014

30,238

Total equity shareholders' funds

755,853

627,814

646,699

Net asset value per share (note 8)

281.78p

232.32p

239.28p

 

Registered in Guernsey

Company registration number: 43298

 

Cash Flow Statement

 

 

(Unaudited)

For the six

months ended

28 February

2021

£'000

(Unaudited)

For the six

months ended

29 February

2020

£'000

(Audited)

For the

year ended

31 August

2020

£'000

Operating activities

 

 

 

Profit/(loss)/before finance costs and taxation

132,869

(34,864)

(3,819)

Deduct net foreign currency gains

(962)

(711)

(3,536)

(Gains)/losses on investments at fair value through profit or loss

(129,359)

42,903

33,379

Net sales/(purchases) of investments at fair value through

 

 

 

profit or loss

11,865

(22,880)

(9,030)

(Increase)/decrease in receivables

(1,367)

1,449

(194)

Increase in payables

5,543

338

70

Overseas taxation paid

(539)

(578)

(2,143)

Net cash inflow/(outflow) from operating activities before interest

18,050

(14,343)

14,727

Interest paid

(169)

(420)

(767)

Net cash inflow/(outflow) from operating activities

17,881

(14,763)

13,960

Financing activities

 

 

 

Bank loans drawn down

-

23,244

87,067

Bank loans repaid

(5,241)

-

(80,351)

Issue of ordinary shares

-

19,397

21,561

Repurchase of ordinary shares into treasury

(5,233)

-

(2,155)

Dividends paid

(17,504)

(17,401)

(27,674)

Net cash (outflow)/inflow from financing activities

(27,978)

25,240

(1,552)

(Decrease)/Increase in cash and cash equivalents

(10,097)

10,477

12,408

Cash and cash equivalents at the start of the period

17,028

5,043

5,043

Effect of foreign exchange rate changes on cash and

 

 

 

cash equivalents

(659)

(1,194)

(423)

Cash and cash equivalents at the end of the period

6,272

14,326

17,028

 

Dividends received during the period amounted to £9,307,000 (period ended 29 February 2020: £10,726,000 and year ended 31 August 2020: £30,561,000) and bond and deposit interest receipts amounted to £nil (period ended 29 February 2020: £10,000 and year ended 31 August 2020: £14,000).

 

Notes to the Accounts

 

1. Principal activity

 

The Company carries on business as a Guernsey closed-ended investment company.

 

2. Financial statements

 

The financial information for the six months ended 28 February 2021 and 29 February 2020 has not been audited or reviewed by the Company's auditor. These financial statements do not include all of the information required to be included in annual financial statements and should be read in conjunction with the financial statements of the Company for the year ended 31 August 2020.

 

3. Accounting policies

 

The accounts have been prepared in accordance with International Accounting Standard 34 "Interim Financial Reporting" and the accounting policies set out in the statutory accounts of the Company for the year ended 31 August 2020. Where presentational guidance set out in the Statement of Recommended Practice (the "SORP") for investment trusts issued by the Association of Investment Companies in October 2019, is consistent with the requirements of International Financial Reporting Standards, the accounts have been prepared on a basis compliant with the recommendations of the SORP.

 

4. Taxation

 

Taxation comprises irrecoverable overseas withholding tax deducted from dividends receivable. The Company became resident in the United Kingdom for taxation purposes on 1 September 2020 and has been granted approval as an investment trust under Sections 1158 and 1159 of the Corporation Taxes Act 2010, from that date.

 

5. Earnings/(losses) per share

 

 

(Unaudited)

Six months

ended

28 February

2021

£'000

(Unaudited)

Six months

ended

29 February

2020

£'000

 

(Audited)

Year ended

31 August

2020

£'000

Net revenue profit

8,624

8,040

26,537

Net capital profit/(loss)

123,267

(44,026)

(33,374)

Net total profit/(loss)

131,891

(35,986)

(6,837)

Weighted average number of shares in issue during the period

269,389,571

267,734,123

269,200,852

Revenue earnings per share

3.20p

3.00p

9.86p

Capital earnings/(loss) per share

45.76p

(16.44)p

(12.40)p

Total earnings/(losses) per share

48.96p

(13.44)p

(2.54)p

 

6. Dividends paid

 

 

(Unaudited)

Six months

ended

28 February

2021

£'000

(Unaudited)

Six months

ended

29 February

2020

£'000

 

(Audited) Year ended

 31 August

2020

£'000

2020 fourth interim dividend of 4.60p (2019: 4.60p)

12,404

12,274

12,274

First interim dividend of 1.90p (2020: 1.90p)

5,100

5,127

5,127

Second interim dividend of 1.90p

-

-

5,138

Third interim dividend of 1.90p

-

-

5,135

 

17,504

17,401

27,674

A second interim dividend of 1.90p (2020: 1.90p) per share, amounting to £5,097,000 (2020: £5,138,000) has been declared payable in respect of the year ending 31 August 2021.

 

7. Share capital

 

Changes in the number of shares in issue during the period were as follows:

 

 

(Unaudited)

Six months

ended

28 February

2021

(Unaudited)

 Six months

ended

29 February

2020

 

(Audited) Year ended 31 August

2020

Ordinary shares of 1p each, allotted, called-up and fully paid

Opening balance of shares in issue, excluding shares held in treasury

 

270,268,024

 

262,683,024

 

262,683,024

Issue of shares

-

7,550,000

8,550,000

Repurchase of shares into treasury

(2,025,000)

-

(965,000)

Closing balance of shares in issue, excluding shares held in treasury

268,243,024

270,233,024

270,268,024

Shares held in treasury

2,990,000

-

965,000

Closing balance of shares in issue

271,233,024

270,233,024

271,233,024

 

8. Net asset value per share

 

 

(Unaudited)

28 February

2021

(Unaudited)

29 February

2020

(Audited)

31 August

2020

Net assets attributable to shareholders (£'000)

755,853

627,814

646,699

Shares in issue at the period end, excluding shares held in treasury

268,243,024

270,233,024

270,268,024

Net asset value per share

281.78p

232.32p

239.28p

 

9. Disclosures regarding financial instruments measured at fair value

 

The Company's portfolio of investments, comprising investments in companies and any derivatives, are carried in the balance sheet at fair value. Other financial instruments held by the Company comprise amounts due to or from brokers, dividends and interest receivable, accruals, cash and drawings on the credit facility. For these instruments, the balance sheet amount is a reasonable approximation of fair value. The recognition and measurement policies for financial instruments measured at fair value have not changed from those set out in the statutory accounts of the Company for the year ended 31 August 2020.

 

The investments in the Company's portfolio are categorised into a hierarchy comprising the following three levels:

Level 1 - valued using quoted prices in active markets.

Level 2 - valued by reference to valuation techniques using observable inputs other than quoted market prices included within Level 1.

Level 3 - valued by reference to valuation techniques using inputs that are not based on observable market data.

 

Categorisation within the hierarchy has been determined on the basis of the lowest level input that is significant to the fair value measurement of the relevant asset.

 

At 28 February 2021, the Company's investment portfolio and derivative financial instruments were categorised as follows:

 

 

(Unaudited)

28 February

2021

£'000

(Unaudited)

29 February

2020

£'000

(Audited) 31 August

2020

£'000

 

 

Level 1

785,355

669,838

672,184

Level 2

-

(361)

-

Level 3

-

-

-

Total

785,355

669,477

672,184

 

There have been no transfers between Levels 1, 2 or 3 during the period (period ended 29 February 2020 and year ended 31 August 2020: nil).

 

10. Events after the interim period that have not been reflected in the financial statements for the interim period

 

The directors have evaluated the period since the interim date and have not noted any events which have not been reflected in the financial statements.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR BRGDULXGDGBS
Date   Source Headline
3rd May 20244:42 pmRNSTransaction in Own Shares
3rd May 202411:00 amRNSNet Asset Value(s)
2nd May 20244:56 pmRNSTransaction in Own Shares
2nd May 202410:47 amRNSNet Asset Value(s)
2nd May 20249:55 amRNSPortfolio Update
1st May 20244:48 pmRNSTransaction in Own Shares
1st May 202410:45 amRNSNet Asset Value(s)
30th Apr 20245:12 pmRNSTotal Voting Rights
30th Apr 20244:40 pmRNSTransaction in Own Shares
30th Apr 202410:23 amRNSNet Asset Value(s)
29th Apr 202410:26 amRNSNet Asset Value(s)
26th Apr 20245:05 pmRNSTransaction in Own Shares
26th Apr 202410:49 amRNSNet Asset Value(s)
25th Apr 20244:27 pmRNSTransaction in Own Shares
25th Apr 202410:47 amRNSNet Asset Value(s)
24th Apr 20245:30 pmRNSTransaction in Own Shares
24th Apr 202410:30 amRNSNet Asset Value(s)
23rd Apr 202411:13 amRNSNet Asset Value(s)
22nd Apr 20244:56 pmRNSTransaction in Own Shares
22nd Apr 202410:37 amRNSNet Asset Value(s)
19th Apr 202410:20 amRNSNet Asset Value(s)
18th Apr 202410:20 amRNSNet Asset Value(s)
17th Apr 20244:35 pmRNSTransaction in Own Shares
17th Apr 202410:40 amRNSNet Asset Value(s)
16th Apr 20244:42 pmRNSTransaction in Own Shares
16th Apr 20243:12 pmRNSDividend Declaration
16th Apr 202410:38 amRNSNet Asset Value(s)
15th Apr 20245:16 pmRNSPortfolio Update
15th Apr 20244:54 pmRNSTransaction in Own Shares
15th Apr 202411:45 amRNSNet Asset Value(s)
12th Apr 20243:35 pmRNSTransaction in Own Shares
12th Apr 202411:08 amRNSNet Asset Value(s)
11th Apr 20244:51 pmRNSTransaction in Own Shares
11th Apr 202410:39 amRNSNet Asset Value(s)
10th Apr 20245:16 pmRNSTransaction in Own Shares
10th Apr 202410:29 amRNSNet Asset Value(s)
9th Apr 20245:30 pmRNSTransaction in Own Shares
9th Apr 202411:09 amRNSNet Asset Value(s)
8th Apr 20244:42 pmRNSTransaction in Own Shares
8th Apr 202411:25 amRNSNet Asset Value(s)
5th Apr 202410:29 amRNSNet Asset Value(s)
4th Apr 20244:37 pmRNSTransaction in Own Shares
4th Apr 202411:05 amRNSNet Asset Value(s)
3rd Apr 20244:45 pmRNSTransaction in Own Shares
3rd Apr 202410:39 amRNSNet Asset Value(s)
2nd Apr 20244:10 pmRNSTransaction in Own Shares
2nd Apr 202411:14 amRNSNet Asset Value(s)
28th Mar 20245:15 pmRNSTotal Voting Rights
28th Mar 20244:54 pmRNSTransaction in Own Shares
28th Mar 202411:21 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.